FDA Approves IOPIDINE 1% — Harrow Eye, LLC

# FDA Approves Harrow Eye's IOPIDINE (Apraclonidine Hydrochloride) for Ophthalmic Use Harrow Eye, LLC has received FDA approval for IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution), positioning the company to capture market share in the ophthalmology segment with a selective alpha-2 adrenergic agonist indicated for ocular hypertension and glaucoma management. The approval strengthens Harrow Eye's ophthalmic portfolio and provides